T. Vanagthoven et al., INDUCTION OF ESTROGEN INDEPENDENCE OF ZR-75-1 HUMAN BREAST-CANCER CELLS BY EPIGENETIC ALTERATIONS, Molecular endocrinology, 8(11), 1994, pp. 1474-1483
Antagonists of steroid hormones are clinically important in the manage
ment of breast cancer. However, the duration of response!s limited due
to the development of hormone-independent tumors in virtually all cas
es. In an attempt to obtain insight into the mechanisms underlying ant
iestrogen resistance, the consequences of epigenetic changes in gene e
xpression were studied in vitro. Estrogen-dependent ZR-75-1 human brea
st cancer cells were treated with 5-azacytidine, an inhibitor of DNA m
ethylation, and cultured in the absence of estradiol or in the presenc
e of antiestrogens. Estrogen-independent cell colonies developed withi
n 3 weeks at high frequency in 5-azacytidine-treated, cultures (0.7 x
10(-3)), in contrast to control Cultures (less than or equal to 10(-8)
). The derived cells (ZR/AZA) were resistant to 4-hydroxy-tamoxifen an
d ICI 164,384, independent of the selection protocol, but had lost the
ability to grow anchorage-independent. Whereas expression of estrogen
receptor, progesterone receptor, and pS2 were down-regulated, express
ion of epidermal growth factor (EGF) receptor and HER2/neu were increa
sed in ZR/AZA cells. In contrast to the stable altered expression patt
erns of estrogen receptor and EGF receptor, transient keratin 7 expres
sion was observed. Transforming growth factor-alpha mRNA was identifie
d in ZR-75-1 cells and ZR/AZA cells and EGF-like peptides were secrete
d in the culture medium. Proliferation of ZR/AZA cells could be partia
lly inhibited with an EGF receptor-blocking antibody. Presence of both
growth factor receptors and possible ligands suggests the development
of an autocrine growth mechanism. Our data show that epigenetic alter
ations of gene expression result in rapid progression of breast cancer
cells to hormone independence.